drugset / Trial / NCT00429182
Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to learn the relationship of high-dose chemotherapy (HDCT) and circulating tumor cells (CTCs) in controlling metastatic breast cancer. The study also will investigate the role of CTCs in breast cancer.
Timeline
- Start
- 2007-06
- Primary completion
- 2012-02
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | 20 unknown | Intravenous |
| Subject | Cyclophosphamide | Other / unclassified | 1500 mg/m2 | Intravenous |
| Subject | Thiotepa | Other / unclassified | 120 mg/m2 | Intravenous |